FDA Inspection 1164414 — HealthPartners Institute IRB

HealthPartners Institute IRB — FEI 2127271

The FDA completed an inspection of HealthPartners Institute IRB on March 14, 2022 in Bloomington, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 14, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Bloomington, MN (United States)

Additional Details

IRB

Citations

IDCFRDescription
728121 CFR 56.108(a)(1)Initial and continuing reviews